Carcinogens

DBCAT000622Pharmacologic class

Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. A DrugBank category of 13 drugs. 4 of them are approved.

Also known as: Initiators, Tumor · Oncogens · Promoters, Tumor · Tumor Initiators · Tumor Promoters
Drugs: 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
Aniline
Bisphenol A diglycidyl ether
Bromoform
Calyculin A
Carbazole
Ciprofibrate
Diethylstilbestrol
Phenethyl Isothiocyanate
Phorbol 12-myristate 13-acetate diester
Pirinixic acid
Sodium nitrate
Urethane

What you can answer from here — as of August 24, 2016

13DrugsEach linked to its full drug card

Listed above

70Drug targetsEvery drug–target pair in the class, with bond type

30Marketed productsAcross the regions we cover, with dosage forms and routes

3Routes of administrationHow the drugs in this class are given

Which targets do Carcinogens share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account